Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Next-Generation Sequencing in Differentiated Thyroid Cancer Patients Treated with Lenvatinib: Results and Challenges in Real-Life Practice.

Current oncology (Toronto, Ont.) - 21 Jun 2026

Ferrari Matteo, Nervo Alice, Maletta Francesca, Mariani Sara, Vaccaro Elisa, Piovesan Alessandro, Arvat Emanuela

Abstract excerpt

OBJECTIVE: Our objectives were to describe molecular profiling in a real-life cohort of patients with radioiodine-resistant (RAI-R) differentiated or poorly differentiated thyroid cancer (DTC or PDTC) treated with lenvatinib and to focus on factors potentially influencing the quality of tissue samples for molecular analysis, including the impact of storage time, defined as the interval between tissue collection...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antineoplastic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to RET gene

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Share to Phenylurea Compounds

Share to Quinolines

Share to Thyroid Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 42346272
DOI: 10.3390/curroncol33060372
PMCID: PMC13298449

Genes

BRAF
RET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Next-Generation Sequencing in Differentiated Thyroid Cancer Patients Treated with Lenvatinib: Results and Challenges in Real-Life Practice.PMID 42346272Read ↗

Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?: A multicenter experience.Semantic proximity Read ↗

Impact of the quality of resected thyroid cancer tissue sample on next-generation sequencing testing.Semantic proximity Read ↗

Next-generation sequencing in thyroid cancer.Semantic proximity Read ↗

Clinical Application of Next-Generation Sequencing in Advanced Thyroid Cancers.Semantic proximity Read ↗

Genomic landscape characterization and comparative analysis of tissue and liquid-based next-generation sequencing in anaplastic thyroid carcinoma in TaiwanSemantic proximity Read ↗

Molecular Profile of Advanced Radioiodine-refractory Thyroid Cancer and Response to Lenvatinib Treatment.Semantic proximity Read ↗

Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer center.Semantic proximity Read ↗

Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer.Semantic proximity Read ↗

Tumor-informed liquid biopsy for monitoring thyroid cancer: a proof-of-concept study.Semantic proximity Read ↗

High prevalence of potential molecular therapeutic targets in poorly differentiated thyroid carcinomaSemantic proximity Read ↗

Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers.Semantic proximity Read ↗

Targeted therapy in thyroid cancer: molecular alterations and clinical management.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.